摘要
乳腺癌是女性最常见的恶性肿瘤之一,每年世界上大约有100万妇女被诊断为乳腺癌,尤其近年来中国乳腺癌发病率快速上升,已是中国女性发病率和死亡率最高的恶性肿瘤,严重威胁女性的健康与生命。
出处
《国际检验医学杂志》
CAS
2012年第13期1632-1634,共3页
International Journal of Laboratory Medicine
参考文献24
-
1Roodman GD. Mechanisms of bone metastasis[J]. N Engl J Med, 2004,350(16) : 1655-1664.
-
2Akhtari M,Mansuri J,Newman KA,et al. Biology of breast canc- er bone metastasis[J]. Cancer Biol Ther, 2008,7 (1) : 3-9.
-
3Cawthorn TR,Amir E,Broom R,et al. Mechanisms and pathways of bone metastasis:challenges and pitfalls of performing molecular research on patient samples[J]. Clin Exp Metastasis,2009,26(8):935-943.
-
4Psaila B,Lyden D. The metastatic niche: adapting the foreign soil[J]. Nat Rev Cancer,2009,9(4) :285-293.
-
5Ye L,Kynaston HG,Jiang WG. Bone metastasis in prostate canc- er:molecular and cellular mechanisms[J]. Int J Mol Med,2007,20 (1) :103-111.
-
6Komori T,Yagi H, Nomura S, et al. Targeted disruption of Cbfal results in a complete laek of bone formation owing to rnaturational arrest of osteoblasts[J]. Cell, 1997,89 (5): 755-764.
-
7Otto F,Thornell AP, Crompton T, et al. Cbfal, a candidate gene for cleidocranial dysplasia syndrome,is essential for osteoblast dif- ferentiation and bone development[J]. Cell, 1997,89 (5) : 765-771.
-
8Tang Y, Wu X, Lei W, et al. TGF-1 induced migration of bone mesenchymal stem cells couples bone resorption with formation [J]. Nat Med,2009,15(7):757-765.
-
9Mohammad KS,Chen CG, Balooch G, et al. Pharmacologic inhibi tion of the TGF-13 type I receptor kinase has anabolic and anti-cat- abolic effects on bone[J]. PLoS One, 2009,4(4) : e5275.
-
10Ferlin A,Pepe A, Facciolli A, et al. Relaxin stimulates osteoclast differentiation and activation[J]. Bone, 2010,46 (2) : 504-513.
同被引文献23
-
1田庆显,黄公怡.1,25-二羟基维生素D_3对小鼠成骨细胞增殖的影响[J].中华老年医学杂志,2006,25(12):922-924. 被引量:9
-
2Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumors.Nature,2000,406 (6797):747-772.
-
3Li Laine Ooia,Yu Zheng A,Kellie Stalgis-Bilinskic,et al.The bone remodeling environment is a factor in breast cancer bone metastasis,Bone,2011,48 (1):66-70.
-
4Rakha EA,EI Sayed ME,Green AR,et al.Prognostic markers in triple-megative breast cancer.Cancer,2007,109(1):25-32.
-
5Buijs JT, van der Pluijm G. Osteotropic cancers: from primary tumor to bone[J]. Cancer Lett, 2009,273(2) :177-193.
-
6Coleman R, Body JJ, Aapro M, et al. Bone health in cancer pa- tients: ESMO Clinical Practice Guidelines[ J]. Ann Oncol, 2014, 25 ( Suppl 3 ) : 124-137.
-
7Erdogan B, Cicin I. Medical treatment of breast cancer bone me- tastasis : from bisphosphonates to targeted drugs [ J ~. Asian Pac J Cancer Prey, 2014,15 ( 4 ) : 1503-1510.
-
8Mastro AM, Gay CV, Welch DR, et al. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation [J]. Cell Biochem, 2004,91 (2) :265-276.
-
9Chen P, Hu P, Xie D, et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer[ J]. Breast Cancer Res Treat, 2010,121 (2) :469477.
-
10Swami S, Krishnan AV, Wang JY, et al. Dietary vitamin D ( 3 ) and 1,25-dihydroxyvitamin D ( 3 ) ( calcitriol ) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer[ J]. Endocrinology, 2012,153 (6) :2576-2587.
引证文献2
-
1王合兵,肖坚,陈文新,杨炳林,韩素梅.乳腺癌分子分型与复发转移部位、时间的相关性研究[J].中国医师杂志,2013,15(7):904-907. 被引量:7
-
2吴玉,卫红艳,翟琼莉.1,25(OH)_2D_3对成骨细胞增殖及其与乳腺癌细胞黏附的影响[J].山东医药,2014,54(39):1-4. 被引量:2
二级引证文献9
-
1王云彬,谢巧卫.分阶段健康教育在乳腺癌手术患者中的应用[J].中国基层医药,2014,21(24):3825-3826. 被引量:4
-
2邱秀娟,刘莹,吾尔满,孟涛,成芳.新疆地区1006例不同分子分型乳腺癌的临床病理特征及预后[J].临床肿瘤学杂志,2015,20(6):525-530. 被引量:3
-
3何健,李素平,唐恭顺.18F-FDG符合线路SPECT显像与螺旋CT在乳腺癌术后转移中的诊断价值比较[J].中国医师杂志,2015,17(8):1164-1166. 被引量:1
-
4唐石初,王志远,欧阳涛.三阴性乳腺癌超声特征探讨[J].中国医师杂志,2015,17(8):1197-1199. 被引量:5
-
5黄丽英,陈夏.没食子酸乙酯对人乳腺癌MDA-MB-231细胞侵袭能力及其作用机制研究[J].癌症进展,2016,14(4):375-377. 被引量:5
-
6何英,邓宏武,万能斌,周征宇.HER2阴性Luminal型乳腺癌的聚类分析及预后比较[J].中国医师杂志,2017,19(5):731-733. 被引量:1
-
7古丽巴哈.买买提,刘玉,赵莉,严媚.1,25(OH)_2D_3对人白血病6T-CEM细胞株凋亡及VDR蛋白表达的影响[J].中国医药导报,2017,14(18):12-15. 被引量:3
-
8马建萍,马芬兰.不同分子分型乳腺癌的临床病理特征及预后的关系[J].实用癌症杂志,2017,32(12):2041-2044. 被引量:28
-
9张晴,王旭波,李丹,岳欣,李彩红.改良根治术后的乳腺癌免疫组化3种分子亚型的预后特性及年复发变化[J].包头医学院学报,2018,34(8):35-36. 被引量:2
-
1杨接来,杨庆诚.骨转移癌微环境与治疗靶点[J].国际肿瘤学杂志,2014,41(11):854-857. 被引量:3
-
2杨自飞,王捷.肿瘤细胞和骨微环境在骨转移中的作用[J].生命的化学,2008,28(6):759-762. 被引量:1
-
3周悦,叶媚娜.骨微环境内细胞因子对乳腺癌骨转移的影响[J].南通大学学报(医学版),2014,34(3):207-211. 被引量:1
-
4闫敏(综述),崔树德(审校),江泽飞(审校).乳腺癌骨转移研究进展[J].国际肿瘤学杂志,2009,36(8):596-599.
-
5初云霞,王秀问.恶性肿瘤骨转移分子机制的研究进展[J].中国肿瘤生物治疗杂志,2009,16(4):422-426. 被引量:14
-
6吴玲,王佳,吴英,夏添松.乳腺癌骨转移过程中的分子机制[J].中国肿瘤外科杂志,2017,9(1):55-57. 被引量:6
-
7严伟,汤亭亭.骨内微环境对乳腺癌骨转移的影响[J].国际骨科学杂志,2012,33(1):45-47. 被引量:1
-
8陈晨,孙蔚莉,陈嘉,霍介格.唑来膦酸在乳腺癌中抗肿瘤作用的研究现状[J].国际肿瘤学杂志,2014,41(3):196-199. 被引量:3
-
9于洋,周立平.乳腺癌骨转移分子机制的研究进展[J].现代肿瘤医学,2014,22(3):693-696. 被引量:17
-
10罗兴训,张燕,朱军,陈琴华.中药治疗乳腺癌骨转移的机制研究进展[J].山西医药杂志,2015,44(23):2752-2755. 被引量:1